Machine learning prediction of HER2-low expression in breast cancers based on hematoxylin–eosin-stained slides

被引：0
|
作者：
Jun Du [1 ]
Jun Shi [2 ]
Dongdong Sun [3 ]
Yifei Wang [4 ]
Guanfeng Liu [4 ]
Jingru Chen [5 ]
Wei Wang [5 ]
Wenchao Zhou [1 ]
Yushan Zheng [2 ]
Haibo Wu [2 ]
机构：
[1] University of Science and Technology of China,Department of Pathology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine
[2] University of Science and Technology of China,Intelligent Pathology Institute, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine
[3] Hefei University of Technology,School of Software
[4] Hefei University of Technology,School of Computer Science and Information Engineering
[5] University of Science and Technology of China,School of Life Sciences, Division of Life Sciences and Medicine
[6] Beihang University,School of Engineering Medicine, Beijing Advanced Innovation Center on Biomedical Engineering
[7] University of Science and Technology of China,Department of Pathology, Centre for Leading Medicine and Advanced Technologies of IHM, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine
来源：
Breast Cancer Research | / 27卷 / 1期
关键词：
Breast cancer; Machine learning; Prediction; Hematoxylin–eosin; HER2;
D O I：
10.1186/s13058-025-01998-8
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] A gene expression-based classifier for HER2-low breast cancer
    Di Cosimo, Serena
    Pizzamiglio, Sara
    Ciniselli, Chiara Maura
    Duroni, Valeria
    Cappelletti, Vera
    De Cecco, Loris
    De Marco, Cinzia
    Silvestri, Marco
    De Santis, Maria Carmen
    Vingiani, Andrea
    Paolini, Biagio
    Orlandi, Rosaria
    Iorio, Marilena Valeria
    Pruneri, Giancarlo
    Verderio, Paolo
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [32] Computational pathology based HER2 expression quantification in HER2-low breast cancer
    Spitzmueller, Andreas
    Kapil, Ansh
    Shumilov, Anatoliy
    Chan, Jessica
    Konstantinidou, Lemonia
    Hassan, Zonera
    Gustavson, Mark
    Carroll, Danielle
    Della Varghese
    James, Gareth D.
    Moh, Akira
    Livingston, Andrew
    de Giorgio-Miller, Victoria
    CANCER RESEARCH, 2023, 83 (05)
  • [33] Comparison of deep learning approaches applied to hematoxylin and eosin-stained whole slide images from women with benign breast disease to predict risk of developing invasive breast cancer
    Saha, Monjoy
    Abubakar, Mustapha
    Rohan, Thomas E.
    Pfeiffer, Ruth M.
    Duggan, Maire A.
    Richert-Boe, Kathryn
    Figueroa, Jonine D.
    Almeida, Jonas S.
    Gierach, Gretchen L.
    CANCER RESEARCH, 2023, 83 (07)
  • [34] HER2-Low expression in primary male breast cancer
    Rudlowski, Christian
    Erices-Leclercq, Melanie
    Nobbe, Katleen
    Baldus, Stephan
    Foerster, Robert
    Foerster, Frank
    Lubig, Sabine
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 29 - 29
  • [35] Dynamic Changes of HER2 Expression in Breast Cancers after Neoadjuvant Chemotherapy with the Inclusion of HER2-low Category
    Karakas, Cansu
    Tyburski, Haley
    Liu, Elena
    Hicks, David
    Zhang, Huina
    LABORATORY INVESTIGATION, 2023, 103 (03) : S151 - S152
  • [36] Machine learning models for differential diagnosing HER2-low breast cancer: A radiomics approach
    Chen, Xianfei
    Li, Minghao
    Su, Danke
    MEDICINE, 2024, 103 (33)
  • [37] AI-based quantification of TILs using hematoxylin and eosin and immunohistochemistry-stained slides in triple-negative breast cancer.
    Kobayashi, Takuma
    Tomioka, Nobumoto
    Hatanaka, Kanako C.
    Konishi, Teppei
    Grynkiewicz, Mateusz
    Komura, Daisuke
    Ishikawa, Shumpei
    Watanabe, Kenichi
    Takahashi, Masato
    Hatanaka, Yutaka
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [38] Comprehensive characterization of HER2-low breast cancers: implications in prognosis and treatment
    Li, Yuyang
    Tsang, Julia Y.
    Tam, Fiona
    Loong, Thomson
    Tse, Gary M.
    EBIOMEDICINE, 2023, 91
  • [39] HER2-low Breast Cancers: Comparison of HER2 Scores by Immunohistochemistry and Oncotype DX
    Chen, Hui
    Wu, Yun
    Ding, Qingqing
    Huo, Lei
    Khazai, Laila
    Sahin, Aysegul
    Albarracin, Constance
    LABORATORY INVESTIGATION, 2023, 103 (03) : S114 - S114
  • [40] HER2-low breast cancers exhibit special biological and prognostic features
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2024, 84 (11)
12345